View all cases
UPC APP 60271/2024
Nov 8, 2024·EP3167888 Unitary patent · TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT
- Case details
- StatusCase ClosedActionGenericCategoryFile-access requests (R. 262.1(b))
- Parties
- Claimants
- Name withheld (GDPR)
Representatives- Jochen Höhfeld
Respondents- Alexion Pharmaceuticals, Inc.Operating co.
- Samsung Bioepis NL B.V.Operating co.
Representatives- Elena Hennecke-Freshfields
- Division
- Hamburg LD
- Technology
- ChemistryBiotechnology · Pharmaceuticals
- Language
- English
- EPO Opposition
- Samsung Bioepis NL B.V.Withdrawn2024-05-02
- Amgen Technology (Ireland) Unlimited CompanyWithdrawn2024-10-28
- Salute HC Ilaç Pazarlama A.S.Admissible2025-01-31
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Hamburg LD | Locked |
| Judge Sabine Klepsch | Locked |
| Judge Alima Zana | Locked |
| Judge Stefan Schilling | Locked |
| Judge Rudi Goedeweeck | Locked |
At the UPC: AstraZeneca Group (13 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patent8 other defendants litigating the same or a related patent
UPC CoA 744/2025·UPC CFI 674/2025·UPC CFI 51/2025·UPC CFI 642/2024·UPC CoA 402/2024 and 3 more
Start a free trial to see how each one ended.
More cases: Hamburg LD·2024
Documents
Show all 20 documents| Document title | Date | Public |
|---|---|---|
| Case closed | 2025-12-05 | Not public |
| redacted version | 2025-04-17 | Not public |
| redacted version | 2025-04-17 | Not public |
| Outcome of the Order | 2025-04-15 | Not public |
| Closing workflow | 2025-04-15 | Public |
| Closing workflow | 2025-04-15 | Not public |
| Outcome of the Order | 2025-04-15 | Not public |
| Order with grounds | 2025-04-15 | Public |
| Order with grounds | 2025-04-15 | Not public |
| Order with grounds | 2025-04-15 | Public |